HOME >> MEDICINE >> NEWS
May/June 2006 Annals of Family Medicine Tip Sheet

es, location of physician training and processes by which physicians determine and negotiate patient and family preferences regarding care.
A Cross-Cultural Study of Physician Treatment Decisions for Demented Nursing Home Patients Who Develop Pneumonia
By Margaret R. Helton, M.D., et al

HOW PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA PERCEIVE RISK
Patients with familial hypercholesterolemia, a genetic disease characterized by high cholesterol and early cardiovascular disease, use a two-step process to develop a personal sense of vulnerability to coronary heart disease. In this qualitative study of 40 patients, participants first consulted their family history to assess their genetic and inherited risk and then negotiated a personal sense of vulnerability through comparisons between themselves and family members. Frich and colleagues assert that in order for physicians to individualize their clinical management of patients, they should determine the patient's understanding of their family history and their personal vulnerability.
Perceived Vulnerability to Heart Disease in Patients with Familial Hypercholesterolemia: A Qualitative Interview Study
By Jan C. Frich, M.D., M.Sc., et al

INHALED CORTICOSTEROIDS AN EFFECTIVE TREATMENT FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
The use of inhaled corticosteroids (ICSs) for treatment of patients with moderate to severe chronic obstructive pulmonary disease (COPD) is effective in improving health outcomes. COPD is one of the leading causes of morbidity and mortality worldwide and the beneficial effect of ICS for treatment remains controversial. This systematic review finds that COPD patients treated with ICSs experienced 33 percent fewer exa
'"/>

Contact: Kristin Robinson
kristinr@aafp.org
913-906-6000 x5221
American Academy of Family Physicians
30-May-2006


Page: 1 2 3 4 5 6 7

Related medicine news :

1. May/June Annals of Family Medicine tip sheet
2. May/June 2005 Annals of Family Medicine tip sheet
3. Annals of Internal Medicine tip sheet for Aug. 7, 2007, issue
4. Annals of Internal Medicine Tip Sheet for May 15, 2007
5. Tip sheet for Annals of Internal Medicine -- May 1, 2007, issue
6. Tip sheet Annals of Internal Medicine, April 17, 2007
7. Embargoed March/April Annals of Family Medicine tip sheet
8. Annals of Internal Medicine tip sheet for March 6, 2007
9. Annals of Internal Medicine tip sheet for Feb. 20, 2007, issue
10. Embargoed Jan./Feb. Annals of Family Medicine tip sheet
11. November/December 2006 Annals of Family Medicine tip sheet

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: May June Annals Family Medicine Tip Sheet

(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
(Date:1/22/2015)... 2015 State Forestry Institute of Mecklenburg-Vorpommern ... with support from GEOSYSTEMS, a dedicated Hexagon Geospatial and ... leverage Hexagon Geospatial’s ERDAS APOLLO for cataloging, ... as point clouds and documents. This effort will enable ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced ... for the compounding, packaging and distributing of its naltrexone tablets. ... the United States . KRS Global ... naltrexone tablets in various strengths for individual patients in response ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: